Last reviewed · How we verify
Fenofibrate 200mg
Fenofibrate 200mg is a Small molecule drug developed by Xijing Hospital of Digestive Diseases. It is currently FDA-approved. Also known as: Fibrate, Fenofibrate group.
Fenofibrate 200mg is a small molecule that acts as a peroxisome proliferator-activated receptor alpha agonist. It is used to treat conditions such as Primary Biliary Cholangitis, Hyperlipoproteinemia, and Severe Hypertriglyceridemia During Pregnancy.
At a glance
| Generic name | Fenofibrate 200mg |
|---|---|
| Also known as | Fibrate, Fenofibrate group |
| Sponsor | Xijing Hospital of Digestive Diseases |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Fenofibrate in Primary Biliary Cholangitis: a Real World Study (PHASE3)
- Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis (PHASE2, PHASE3)
- FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy (PHASE3)
- A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis (EARLY_PHASE1)
- Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma (PHASE1)
- Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC) (EARLY_PHASE1)
- Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females (PHASE4)
- Safety Study of Fenofibrate During Pregnancy
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fenofibrate 200mg CI brief — competitive landscape report
- Fenofibrate 200mg updates RSS · CI watch RSS
- Xijing Hospital of Digestive Diseases portfolio CI
Frequently asked questions about Fenofibrate 200mg
What is Fenofibrate 200mg?
Who makes Fenofibrate 200mg?
Is Fenofibrate 200mg also known as anything else?
What development phase is Fenofibrate 200mg in?
Related
- Manufacturer: Xijing Hospital of Digestive Diseases — full pipeline
- Also known as: Fibrate, Fenofibrate group
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing